MichaelAStellerMD
Obstetrics & Gynecology • Boston, MAGynecologic Oncology
Clinical Professor, Obstetrics and Gynecology, Tufts Medical Center
Dr. Steller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
736 Cambridge St
Boston, MA 02135Phone+1 617-562-7406Fax+1 617-562-7021
Education & Training
Duke University HospitalResidency, Obstetrics and Gynecology, 1986 - 1990
Lewis Katz School of Medicine at Temple UniversityClass of 1986
Certifications & Licensure
RI State Medical License 1997 - 2026
MA State Medical License 1990 - 2021
CT State Medical License 1998 - 2007
MD State Medical License 1996 - 1999
NC State Medical License 1988 - 1998
DC State Medical License 1994 - 1997- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2012-2013
- Boston Magazine Castle Connolly, 2008
- Fellow (FACS) American College of Surgeons
- Join now to see all
Clinical Trials
- Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer Start of enrollment: 1999 Nov 01
Publications & Presentations
PubMed
- 132 citationsCell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7Michael A. Steller, Karen J. Gurski, Masaru Murakami, Richard W. Daniel, Keerti V. Shah
Clinical Cancer Research. 1998-09-01 - 35 citationsInsulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cellsMichael A. Steller, Cynthia H. Delgado, Zhiqiang Zou
Proceedings of the National Academy of Sciences of the United States of America. 1995-12-19 - 47 citationsTumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion.Roya Dadmarz, Aida Ordoubadi, Arnold Mixon, Carolyn O. Thompson, Kathleen C. Barracchini
The Cancer Journal from Scientific American. 1996-09-01
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
